Sonic Incytes Receives FDA 510(k) Clearance of AI Powered Features for Velacur™️ Liver Ultrasound Read More » May 4, 2023
Sonic Incytes Announces New Non-Dilutive Funding to Enhance Company’s Velacur™️ Medical Device Read More » January 18, 2023
Sonic Incytes Announces Clinical Trial Data Comparing Velacur™️ and FibroScan® Read More » November 3, 2022
Sonic Incytes Announces Velacur™️ use in Madrigal Pharmaceuticals’ Open-Label Extension Clinical Trial Read More » June 13, 2022
